Correlation of human neutrophil secretion, chemoattractant receptor mobilization, and enhanced functional capacity.
Open Access
- 1 February 1982
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 128 (2) , 941-948
- https://doi.org/10.4049/jimmunol.128.2.941
Abstract
Studies were performed to elucidate further the phenomenon of secretagogue-mediated enhancement in the binding of the chemoattractant f-met-leu-[3H]phe to human neutrophils (PMN). Specific f-met-leu-[3H]phe binding to unstimulated PMN reached maximum levels after 10 to 15 min of incubation at 0 degrees C with a saturating concentration of peptide, and consisted of a readily displaceable and a nondisplaceable component. PMN, preexposed to A23187 (2.5 X 10(-8) M) or PMA (0.5 ng/ml) for 30 min at 37 degrees C to stimulate limited and preferential release of specific (secondary) granules (10 to 20% of total lysozyme, no beta-glucuronidase), demonstrated an approximate doubling in the displaceable component of f-met-leu-["3H]phe binding, accompanied by an increasing nondisplaceable component that could not be explained by bulk pinocytosis of extracellular fluid (assessed by [3H]sucrose uptake). The increase in f-met-leu-[3H]phe binding was not affected by inhibitors of protein synthesis, could not be attributed to the secreted products lysosyme or lactoferrin acting on the cell, and, on the basis of studies with PMN from patients with chronic granulomatous disease, could not be attributed to the effects of reactive oxygen species generated in low concentration during stimulation. Functional studies on PMN indicated that preexposure to secretagogues at concentrations demonstrated to increase receptor availability also enhanced subsequent f-met-leu-phe-mediated superoxide and hydrogen peroxide generation. The present data demonstrate that secretagogues may activate PMN to enhance their subsequent responses in f-met-leu-phe-mediated processes, and, combined with previous reports, support the concept that specific granules provide a source of preformed membrane and receptor material that is translocated to the cell surface during the secretion associated with directed locomotion.This publication has 16 references indexed in Scilit:
- Degranulating stimuli increase the availability of receptors on human neutrophils for the chemoattractant f-met-leu-phe.The Journal of Immunology, 1980
- Phorbol myristate acetate-induced release of granule enzymes from human neutrophils: Inhibition by the calcium antagonist, 8-(N,N-diethylamino)-octyl 3,4,5-trimethoxybenzoate hydrochlorideBiochemical and Biophysical Research Communications, 1979
- Modulation of neutrophil function by lysozyme. Potential negative feedback system of inflammation.Journal of Clinical Investigation, 1979
- Secretory Responses of Human Neutrophils: Exocytosis of Specific (Secondary) Granules by Human Neutrophils during Adherence in vitro and during Exudation in vivoThe Journal of Immunology, 1979
- Role of secretory events in modulating human neutrophil chemotaxis.Journal of Clinical Investigation, 1978
- Specific receptor sites for chemotactic peptides on human polymorphonuclear leukocytes.Proceedings of the National Academy of Sciences, 1977
- Demonstration of a receptor on rabbit neutrophils for chemotactic peptidesBiochemical and Biophysical Research Communications, 1977
- UV-Assay with Pyruvate and NADHPublished by Elsevier ,1974
- Photometric Determination of Lysozyme Activity.Experimental Biology and Medicine, 1955
- CHROMOGENIC SUBSTRATES .2. PHENOLPHTHALEIN GLUCURONIC ACID AS SUBSTRATE FOR THE ASSAY OF GLUCURONIDASE ACTIVITY1946